Clinical trialNCT02470208CompletedObservational

Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation

SponsorOxford ImmunotecEnrollment250Infection

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the ability of the T-SPOT.CMV assay to determine immune competence against CMV infection in stem cell transplantation. To determine the utility of the T-SPOT.CMV assay used before transplantation to determine immune competence against subsequent CMV reactivation and to determine the utility of the T-SPOT.CMV assay used after transplantation to determine immune competence against subsequent CMV reactivation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Roy F Chemaly, MD
M.D. Anderson Cancer Center
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

University Health Network
Toronto, Ontario, Canada

Sweden

Karolinska Univeristy Hostpital
Stockholm, Sweden

United States

City of Hope
Duarte, California, United States
Ucla Medical Center
Los Angeles, California, United States
the University of Chicago Medicine
Chicago, Illinois, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Umass Memorial Medical Center
Worcester, Massachusetts, United States
Wayne State University - School of Medicine
Detroit, Michigan, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Cleveland Clinic
Cleveland, Ohio, United States
the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2015
Primary completion: 31 Jul 2017
Completion: 31 Jul 2017
Last update posted: 19 Sept 2017
Registered enrollment: 250
Registry id: NCT02470208

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.